GEP-44

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameGEP-44
Drug Alias NameGlucagon-like peptide 1 receptor agonist/neuropeptide Y1-receptor agonist/neuropeptide Y2-receptor agonist (Syracuse University)GEP-44
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsNeuropeptide Y receptor type 2 agonistsNeuropeptide Y receptor type 1 agonists
TargetsGlucagon-like peptide 1 receptorNeuropeptide Y receptor type 1Neuropeptide Y receptor type 2
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSyracuse University
China Registration ClassN/A

Develop Information

Active CompaniesSyracuse University
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A